Sarver Vrooman Wealth Advisors’s iShares iBonds Dec 2034 Term Corporate ETF IBDZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$42.3M Buy
1,718,835
+37,801
+2% +$963K 24.91% 3
2026
Q2
$43.6M Buy
1,681,034
+26,060
+2% +$679K 25.98% 3
2026
Q1
$43.1M Buy
1,654,974
+1,633,901
+7,754% +$43.1M 26.56% 3
2025
Q4
$556K Buy
21,073
+464
+2% +$12.3K 0.35% 10
2025
Q3
$546K Buy
20,609
+10,943
+113% +$287K 0.35% 10
2025
Q2
$253K Buy
9,666
+470
+5% +$12K 0.17% 12
2025
Q1
$237K Buy
+9,196
New +$235K 0.16% 11

Other funds holding IBDZ

Sarver Vrooman Wealth Advisors's IBDZ Position: Q3 2026 in Review

Sarver Vrooman Wealth Advisors increased its iShares iBonds Dec 2034 Term Corporate ETF (IBDZ) stake by 2.2% in Q3 2026, buying an estimated $963K and bringing the position to 1,718,835 shares worth $42.3M. The position accounts for 24.91% of the portfolio, ranked #3.

Sarver Vrooman Wealth Advisors first reported a position in IBDZ in Q1 2025 and has held it in 7 quarters since. The position peaked at $43.6M in Q2 2026. 4 funds tracked by Wall St. Rank hold IBDZ as of Q3 2026.

  • Sarver Vrooman Wealth Advisors held 1,718,835 shares of iShares iBonds Dec 2034 Term Corporate ETF worth $42.3M as of Q3 2026.
  • Sarver Vrooman Wealth Advisors bought 37,801 iShares iBonds Dec 2034 Term Corporate ETF shares in Q3 2026, an estimated $963K.
  • iShares iBonds Dec 2034 Term Corporate ETF made up 24.91% of Sarver Vrooman Wealth Advisors's portfolio in Q3 2026, its #3 holding.
  • Sarver Vrooman Wealth Advisors first reported a position in iShares iBonds Dec 2034 Term Corporate ETF in Q1 2025 and has held it in 7 quarters since.
  • Sarver Vrooman Wealth Advisors's iShares iBonds Dec 2034 Term Corporate ETF position peaked at $43.6M in Q2 2026.
  • 4 funds tracked by Wall St. Rank held iShares iBonds Dec 2034 Term Corporate ETF as of Q3 2026.

Based on Sarver Vrooman Wealth Advisors's 13F filing for Q3 2026, filed 1 Oct 2026.